On Oct. 26, biotech company Celgene (NASDAQ:CELG) released third-quarter earnings for the period ended Sept. 30.
- Revenues and earnings per share were up significantly over last year.
- Revenues rose by 89% to $245 million on account of strong sales of Revlimid and Thalomid.
- GAAP net income increased to $20 million due to higher sales.
(Figures in millions, except per-share data)
Income Statement Highlights
|
Avg. Est. |
Q3 2006 |
Q3 2005 |
Change | |
|---|---|---|---|---|
|
Sales |
$228 |
$244.8 |
$129.5 |
89.0% |
|
Net Profit* |
-- |
$20.4 |
$0.7 |
2,814.3% |
|
EPS |
$0.14 |
$0.05 |
$0.00 |
0% |
|
Diluted Shares |
-- |
404.9 |
359.7 |
12.6% |
Get back to basics with a look at the income statement.
Margin Checkup
|
Q3 2006 |
Q3 2005 |
Change* | |
|---|---|---|---|
|
Gross Margin |
86.03% |
79.63% |
16.40 |
|
Operating Margin |
22.17% |
7.74% |
14.43 |
|
Net Margin |
8.35% |
0% |
8.35 |
Margins are the earnings engine. See how they work.
Balance Sheet Highlights
|
Assets |
Q3 2006 |
Q3 2005 |
Change |
|---|---|---|---|
|
Cash + ST Invest. |
$872.5 |
$746 |
17.0% |
|
Accounts Rec. |
N/A |
$61.6 | N/A |
|
Inventory |
N/A |
$31.7 | N/A |
|
Liabilities |
Q3 2006 |
Q3 2005 |
Change |
|---|---|---|---|
|
Accounts Payable |
N/A |
$27.0 | N/A |
|
Long-Term Debt |
$400 |
$400 |
(0.0%) |
Learn the ways of the balance sheet.
Cash Flow Highlights
This information wasn't available in the press release.
Find out why Fools always follow the money.
Related companies:
- Biogen Idec (NASDAQ:BIIB)
- Amgen (NASDAQ:AMGN)
- OSI Pharmaceuticals (NASDAQ:OSIP)
- Genzyme (NASDAQ:GENZ)
- ImClone Systems (NASDAQ:IMCL)
Related Foolishness:
Biogen Idec is a Motley Fool Stock Advisor selection.For a fun new way to do research on stocks, check out CAPS, the Fool's new investment community.
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.
